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Abstract
Background: Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables that exerts anti-oxidant, anti-
inflammatory, anti-cancer and radio-sensitizing activities. Nonetheless, the mechanism responsible for SFN-induced
cell death is not fully understood. In the present study, anti-cancer mechanism of SFN was elucidated in LNCaP
prostate cancer cells.
Results: SFN exerted cytotoxicity and increased TUNEL positive cells in a concentration-dependent manner in
LNCaP cells. Proteomics study revealed that levels of nine proteins including tubulin b-2, phosphoglucomutase-3
(PGM3), melanoma-derived leucine zipper containing extra-nuclear factor, activin A type I receptor precursor,
smoothelin-A, KIA0073, hypothetical protein LOC57691 and two unnamed proteins were changed over 8 folds in
SFN treated LNCaP cells compared to untreated control. We have further confirmed that SFN reduced PGM3
expression with western blotting and showed that PGM3 siRNA enhanced cytotoxicity demonstrated by cell
morphology and TUNEL assays in LNCaP cells.
Conclusion: Taken together, these findings suggest that PGM3 plays a role in mediating SFN-induced cell death in
LNCaP cells, and is a potential molecular therapeutic target for prostate cancer.
Background
Cell death is defined as an irreversible loss of plasma
membrane integrity. Historically, three types of cell
death have been distinguished in mammalian cells by
morphological criteria, namely apoptosis, autophagy and
necrosis [1]. Apoptosis represents a major regulatory
mechanism that eliminates abundant and unwanted cells
during embryonic development, growth, differentiation
and normal cell turnover [2,3]. Recently, targeting apop-
tosis is thought to be a potential therapeutic approach
for cancer treatment.
Prostate cancer develops in nearly 30% of all men
above the age of 50 years [4] and may metastasize to
other parts of the human body, especially bones and
lymph nodes. Many chemotherapeutic agents such as
Eulexin, Flutamide and Nilandron have been developed
for the treatment of prostate cancer. However, undesir-
able side effects such as urinary incontinence and erec-
tile dysfunction can reduce the therapeutic efficacy of
prostate cancer. In this regard, recent reports have
reported the possibility to use natural compounds as
chemopreventive candidates by inducing apoptotic cell
death in prostate cancer cells [5-9].
Sulforaphane (SFN) (Additional file 1: figure S1) is a
breakdown product of Glucoraphanin which is the com-
pound present in cruciferous vegetables [10]. Many
groups reported that SFN induced apoptosis though
activation of caspase-3 and cell cycle arrest in prostate
cancer cells [11,12]. However, its exact molecular
mechanisms whereby SFN mediates apoptosis are not
fully understood. Thus, in the present study, anti-cancer
mechanisms of SFN to induce apoptosis were investi-
gated by a comparative proteomic analysis. We here
demonstrate that phosphoglucomutase-3 (PGM3) plays
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LNCaP prostate cancer cells.
Results
Sulforaphane exerts cytotoxicity and induces apoptosis in
LNCaP cells
XTT assay was performed to investigate cytotoxic effect
of SFN in LNCaP cells treated with various concentra-
tions (0, 25, 50 or 100 μM) of SFN for 24 h. As shown in
Figure 1A, SFN exerted cytotoxicity against LNCaP cells
in a concentration-dependent manner. To confirm the
cytotoxicity of SFN against LNCaP cells, morphological
changes were observed under an inverted microscope.
The dead cell morphology with swelling and apoptotic
shrinkage were observed in SFN-treated LNCaP cells as
compared with untreated control (Figure 1B).
To assess whether the cytotoxic property of SFN
against LNCaP cells is linked to apoptosis, TUNEL assay
was carried out. As shown in Figure 2A, SFN increased
TUNEL positive cells in a concentration-dependent
manner compared with untreated control. Further, SFN
clearly induced the cleavages of PARP as well as
caspase-3 (Figure 2B). These results indicate that SFN
induces apoptotic cell death in LNCaP cells.
Differential protein profiles of SFN-treated and -untreated
LNCaP cells
To understand the molecular mechanisms underlying
SFN-induced apoptosis in LNCaP cells, 2-DE and gel sli-
ver stain were conducted to analyze the changes in pro-
tein expressions. Representative 2-DE gel images for
SFN-treated and control cells are shown in Figure 3A.
Gel images were analyzed via PD-Quest software and
detected about 1800 protein spots with pI between 3
and 10, and 300 protein spots were found to show the
significantly different expressions between untreated
control and SFN-treated cells (p < 0.05). These spots
were cut from the gels and further identified by Ettan
MALDI-TOF MS/MS analysis. Finally, we identified 9
protein spots exhibiting over 8-fold increase or decrease
in abundance in replicate gels: tubulin beta-2 (spot 509),
phosphoglucomutase 3 (PGM3) (spot 4620), unnamed
protein product (spot 5728), smoothelin-A (spot 6011),
KIAA0073 (spot 7414), Melanoma-derived leucine zip-
per, extra-nuclear factor (spot 8010), unnamed protein
product (spot 8210), hypothetical protein LOC57691
(spot 8405), activin A type I receptor precursor (spot
8714) (Figure 3B and Table 1).
Figure 1 Effect of sulforaphane on the cell viability in LNCaP
cells. (A) Cells were treated with 0, 25, 50 or 100 μM SFN for 24 h.
Cell viability was determined by the XTT assay. Data represent
means ± SD. (B) Morphological changes of SFN-treated LNCaP cells
by inverted microscopy.
Figure 2 Effect of sulforaphane on apoptosis induction in
LNCaP cells. (A) TUNEL assay was carried out in LNCaP cells treated
with or without SFN (80 μM) for 24 h and fluorescence images
were visualized under an Axio vision 4.0 fluorescence microscope
(×630). (B) Cells were treated with SFN (0, 40 or 80 μM) for 24 h.
Cell lysates were prepared and subjected to Western blotting for
PARP and cleaved caspase-3.
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apoptosis in LNCaP cells
Among nine identified proteins, PGM3 was chosen to
further investigate its role in SFN-induced apoptosis in
LNCaP cells. Cells were treated with various concentra-
tions of SFN (0, 20, 40 or 80 μM) for 24 h and subjected
to Western blot analysis with anti-PGM3 antibody. SFN
modestly reduced the level of PGM3 between 10 μM
and 40 μM and completely suppressed PGM3 at 80 μM.
(Figure 4A).
To examine whether PGM3 is related to SFN-induced
apoptosis in LNCaP cells, cell death was analyzed in
Figure 3 Effect of sulforaphane on protein expression by proteomics analysis. (A) Representative silver nitrate staining pattern in SFN (80
μM) treated LNCaP cells. Proteins (200 μg) were separated on pH 4-10 nonlinear IPG strip in the first dimension and 12% homogenous SDS-
PAGE in the second dimension. Staining was performed with alkaline silver. (B) Gel image regions of SFN-treated group and untreated control
with differentially expressed protein spots identified by Ettan MALDI-TOF analysis.
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absence or presence of SFN. Western blotting shown in
Figure 4B revealed that PGM3 siRNA clearly suppressed
PGM3 protein expression, while control siRNA did not
affect PGM3 expression. Also, PGM3 siRNA transfection
effectively inhibited the growth of LNCaP cells compared
with siRNA control (Figure 4C). As shown in Figure 4D,
morphological changes and growth inhibition were
observed in LNCaP cells transfected by PGM3 siRNA
under inverted microscopy. Furthermore, co-treatment
with SFN and PGM3 siRNA synergistically increased the
number of TUNEL-positive cells (Figure 4E), suggesting
that PGM3 may be involved in mediating SFN-induced
cell death in LNCaP cells.
Discussion
Foods of cruciferous vegetables such as broccoli, cab-
bage, and kale are known for their anti-cancer activities
against various types of cancers [13-17]. The anti-cancer
effects of cruciferous vegetables were reported to be
mainly due to the high levels of glucosinolates, which,
following hydrolysis by the enzyme myrosinase, result in
the formation of isothiocyanates [10,16]. Of the isothio-
cynates, SFN is an effective chemoprotective agent in
carcinogen-induced animal models [18-20], and xeno-
graft models of prostate cancer [21]. Recent works also
showed the multifunctional action of SFN as Phase 2
enzyme inducer, cell cycle arrest and apoptosis [22-26].
Prostate cancer is the second leading cause of cancer-
related death in men. Prostate adenocarcinoma is con-
sidered a disease of older men. However, almost one
third of these men harbor evidence of the disease (high-
grade prostatic intraepithelial neoplasia) between the age
of 30 and 40 years. Epidemiological studies suggest that
cruciferous vegetable intake may lower overall risk of
prostate cancer, particularly during the early stages
[27-30]; hence there are growing interests in identifying
the specific chemopreventive agents from medicinal
plants and in elucidating their mechanisms.
There are evidences that SFN can be a cancer preven-
tive candidate for prostate cancer treatment. Herman-
Antosiewicz et al. demonstrated that SFN-induced p21
protein protects against SFN-induced mitotic arrest in
LNCaP prostate cancer cells [31]. Cho et al. demon-
strated that SFN mediated the activation of c-Jun
N-terminal kinase and caspase-mediated apoptosis in
DU145 prostate cancer cells [11]. Nonetheless, the
mechanisms of SFN in LNCaP prostate cancer cells still
remain unveiled. Thus, in the present study, we investi-
gated anti-cancer mechanisms of SFN in LNCaP cells by
protemic analysis. SFN exerted cytotoxicity against
LNCaP cells in a concentration-dependent manner with
IC50 of ~62.5 μM (Figure 2A). Consistent with the
results of previous reports [12,32], SFN increased DNA
fragmentation, a hallmark of apoptosis, in TUNEL assay
(Figure 2C) and cleaved PARP and activated caspase-3
(data not shown), suggesting the apoptotic effects of
SFN in LNCaP cells.
Proteomics is the high-throughtput, large-scale, mainly
automated analysis of protein mixtures to determine the
expression level and post-translational modification of
the proteins [33]. Proteomic analysis was performed to
evaluate the mechanism of SFN-induced cell death in
LNCaP cells. Nine protein spots from a total of ~1800
protein spots were selected for further study due to
their most significant changes between SFN-treated
group and untreated control in LNCaP cells. Three
proteins were significantly down-regulated, including
tubulin b-2 (NP_006079), phosphoglucomutase 3
(CAI22635) and unnamed protein product (BAB85079).
In contrast, six proteins were significantly up-regulated,
including melanoma-derived leucine zipper, extra-
nuclear factor (AAH63595), activin A type I receptor
precursor (NP_001096), smoothelin-A (AAF03563),
Table 1 Effect of SFN on the significantly changed protein expressions
Spot
No.
Protein name NCBI accession
No.
Mr pI SC
(%)
Expression of SFN-treated LNCaP
cells
509 Tubulin, beta 2 NP_006079 52.68 4.37 35 decrease
4620 Phosphoglucomutase 3 CAI22635 55.93 5.8 22 decrease
5728 unnamed protein product BAB85079 59.59 6.3 26 decrease
8010 Melanoma-derived leucine zipper, extra-nuclear
factor
AAH63595 57.93 5.5 9 decrease
8210 unnamed protein product BAC03859 39.90 4.6 20 increase
8714 Activin-A type I receptor precursor NP_001096 58.33 7.2 11 increase
6011 Smoothelin-A AAF03563 50.84 9.9 17 induce
7414 KIA0073 BAA07555 74.00 6.7 10 induce
8405 hypothetical protein LOC57691 NP_065982 90.63 8.1 10 induce
SC (%): Sequence coverage (%).
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(NP_065982) and unnamed protein product
(BAC03859) (Figure 3B and Table 1).
Of these proteins, tubulin b-2, a member of tubulin
protein which is a major component of the cytoskeleton,
was known to be targeted in chemotherapeutic agents
such as taxane and Vinca alkaloid-induced apoptosis in
cancer cells [34,35]. Smoothelin is a cytoskeletal protein
which is generally found in smooth muscle cells [36]
and consists of isoforms smoothelin-A and -B. Smoothe-
lin-A was reported to be increased in expression in
smooth muscle cells in apoptosis induced by pre-B-cell
colony- enhancing factor (PBEF) [37]. These reports are
consistent with our proteomics observations on these
two proteins, and also support our proteomics identifi-
cation of PGM3 as a mediator of apoptosis.
PGM3 is a member of the hexose-phosphate mutase
family and essentially functions in glycogenolysis and gly-
cogenesis [38]. In normal prostate cells, androgen with-
drawal induces apoptosis and develops to prostate cancer
[39]. However, considering that androgen metabolism is
associated with the regulation of glycolytic enzymes and
pentose-phosphate pathway [40], Pang’sr e p o r tt h a t
PGM3 converts glucose-1-phosphate to glucose-6-phos-
phate and mediates glycolysis as well as pentose phos-
phate shunt [38] suggests the possible involvement of
PGM3 in prostate cancer metabolism. In light of these
events, we considered that PGM3 may play a role in the
regulation of prostate cancer cell survival. Our Western
blotting results demonstrated that SFN significantly
decreased the expression of PGM3 in a concentration-
dependent manner in LNCaP cells and clearly suppressed
at 80 μM of concentration (Figure 4A). According to
Gasper and Pledgie-Tracy’s studies, SFN can reach at
high concentration to human prostate tissues physiologi-
cally and be restrained in various tissues including pros-
tate [41,42]. Consistent with the results of Western
blotting, TUNEL assay revealed that PGM3 siRNA
increased green fluorescence TUNEL positive cells and
also enhanced SFN induced apoptosis compared with
control siRNA (Figure 4D).T h e s ed a t aa n dp r e v i o u s
reports suggest that PGM3 mediates SFN induced cell
death in LNCaP cells, possibly via cancer metabolism.
Conclusions
In summary, SFN effectively activated caspase-3 and
increased TUNEL positive cells in LNCaP cells. Using
proteomics analysis, we have identified nine proteins that
might be involved in SFN induced apoptosis in LNCaP
cells. Among them, we have verified SFN-reduced PGM3
expression, and demonstrated that PGM3 siRNA
enhanced cytotoxicity and increased TUNEL positive
cells in LNCaP cells compared to control. Our findings
suggest that PGM3 is involved in mediating SFN-induced
cell death in LNCaP cells and may be a potential molecu-
lar target for prostate cancer therapeutics.
Methods
Materials
L-Sulforaphane (purity ≥ 98%) (Figure 1), urea, thiourea,
3-[(3-cholamidopropy) dimethyammonio]-1-propanesul-
fonate (CHAPS), dithiothreitol (DTT), benzamidine,
Figure 4 Role of PGM3 in sulforphane-induced apoptosis in
LNCaP cells. (A) Effect of SFN on the expression of PGM3 protein
in LNCaP cells treated with SFN (0, 20, 40 or 80 μM), examined by
Western blotting. (B and C) Cells were transiently transfected with
control or PGM3 siRNA. PGM3 expression was analyzed at protein
and mRNA levels by Western blotting (B) and RT-PCR (C),
respectively. (D) Effect of PGM3 siRNA on cytotoxic morphological
changes in LNCaP cells treated with or without SFN. (E) TUNEL assay
in PGM3 transfected LNCaP cells with or without SFN (40 μM) under
an Axio vision 4.0 fluorescence microscope (×630).
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mide, sodium dodecyl sulphate (SDS), acetonitrile, tri-
fluoroacetic acid and a-cyano-4-hydroxycinnamic acid
were purchased from Sigma-Aldrich Co. (St. Louis,
MO). Pharmalyte (pH 3.5-10), IPG DryStrips (pH 4-10
NL, 24 cm) and Modified porcine trypsin (sequencing
grade) were from Amersham Biosciences, Genomine
Inc. and Promega (Maison, WI), respectively.
Cell culture
LNCaP cells were purchased from the American Type
Culture Collection (ATCC) (Manassas, VA) and main-
tained in RPMI 1640 supplemented with 10% fetal
bovine serum (Welgene, Korea), 2 mmol/L L-glutamine,
10 mmol/L HEPES, 1 mmol/L sodium pyruvate and
45 g/L glucose with antibiotics at 37°C in a humidified
atmosphere containing 5% CO2.
Cytotoxicity assay
The cytotoxicity of SFN was assessed by XTT assay as
described previously [43]. Cells were seeded onto 96-
well microplates at a density of 1 × 10
4 cells per well in
100 μl of RPMI 1640 medium and grown for 24 h.
Then the cells were exposed to various concentrations
(0, 25, 50 or 100 μM) of SFN in serum-free medium for
24 h and 50 μl of XTT (1 mg/ml in phosphate buffered
saline (PBS)) mixture containing phenazine methosulfate
(PMS) (1.53 mg/ml in PBS) at the ratio of 100:1 was
added to the cells. Cells were incubated at 37°C for 2 h
and the optical density was measured using microplate
reader (Molecular Devices Co.) at 450 nm. Cell viability
was calculated as a percentage of viable cells in SFN-
treated group versus untreated control using the follow-
ing equation:
Cell  viability  OD SFN OD blank OD control OD bl (%) [ / = () − ()( ) − a ank () × ]. 100
Two-dimensional polyacrylamide gel electrophoresis
(2DE-PAGE)
Cells were treated with or without SFN (80 μM) for 24
h, homogenized using mortor-driven homogenizer
(PowerGen125, Fisher Scientific) in lysis buffer (7 M
urea, 2 M thiourea containing 4% CHAPS, 1% DTT and
2% pharmalyte, and 1 mM benzamidine) and incubated
for 1 h at room temperature. After centrifugation at
15,000× g for 1 h at 15°C, soluble fraction was collected
and used for two-dimensional gel electrophoresis. Pro-
tein concentration was measured by the Bradford assay.
The first-dimensional isoelectric focusing (IEF) was
carried out on Pharmacia Immobiline IPG DryStrip sys-
tem (Uppsala, Sweden). For the first dimension of elec-
trophoresis, the samples containing 100 μgp r o t e i nf o r
analysis gels were diluted to 350 μLw i t har e h y d r a t i o n
solution (7 M urea, 2% w/v CHAPS, 50 mM DTT, 0.5%
v/v IPG buffer (pH 3-10 nonlinear and pH 4-7 linear),
and trace bromophenol blue) before loading onto 17 cm
IPG strips (pH 3-10 nonlinear and pH 4-7 linear). IEF
was then performed using IPG electrophoresis unit
according to the manufacturer’s instructions. Thereafter,
the strips were equilibrated with a solution (6 M urea,
30% v/v glycerol, 2% w/v SDS, and 50 mM Tris-HCl,
pH 8.8), reduced with 1% w/v DTT for 15 min, and
alkylated with 2.5% w/v iodoacetamide for 15 min.
Strips were then rinsed in electrophoresis buffer
(25 mM Tris base, 192 mM glycine, and 0.1% w/v SDS),
applied to 11% acrylamide gels, and sealed with melted
agarose (0.5% w/v agarose in electrophoresis buffer con-
taining a trace of bromophenol blue). SDS-PAGE was
carried out using Hoefer SE 600 vertical chambers and a
Tris-glycine buffer (25 mM Tris and 192 mM glycine)
containing 0.1% w/v SDS, with initial separation at a
constant 10 mA/gel for 30 min followed by 20 mA/gel.
The second-dimensional SDS-PAGE was developed
until the bromophenol blue dye marker had reached the
bottom of the gel. The total run time was typically 4 to
4.5 hours. Gels were fixed in 10% v/v acetic acid, 40% v/
v ethanol before sensitization for 30 min in a buffer
containing 30% v/v ethanol, 0.2% w/v sodium thiosul-
phate, and 0.83 M sodium acetate. This was followed by
three 15 min washes in deionised water. The proteins
were then stained with 0.1% w/v silver nitrate for 20
min, washed twice in deionised water for 1 min, and
developed in 2.5% w/v sodium carbonate containing
0.04% v/v formaldehyde (37% solution). The develop-
ment was stopped with 1% v/v acetic acid, and the gels
were washed three times in water.
Image analysis
Quantitative analysis of digitized images was carried out
using the PDQuest (version 7.0, BioRad) software
according to the protocols provided by the manufac-
turer. Quantity of each spot was normalized by total
valid spot intensity. Protein spots with intensity changed
over two folds compared with control samples were
selected for further studies.
Enzymatic digestion of protein in-gel
Protein spots were enzymatically digested in-gel similar
to that described by Shevchenko et al [44] but modi-
fied using porcine trypsin. Gel pieces were washed
with 50% acetonitrile to remove SDS, salt and stain,
dried to remove solvent and then rehydrated in Tryp-
sin (8-10 ng/μl) Digest Solution and incubated 8-10 h
at 37°C. The proteolytic reaction was terminated by
addition of 5 μl 0.5% trifluoroacetic acid. Tryptic pep-
tides were recovered by combining the aqueous phase
from several extractions of gel pieces with 50%
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mixture was desalted using C18ZipTips (Millipore), and
peptides eluted in 1 to 5 μl of acetonitrile. An aliquot
of this solution was mixed with an equal volume of a
saturated solution of a-cyano-4-hydroxycinnamic acid
in 50% aqueous acetonitrile, and 1 μlo fm i x t u r e
spotted onto a target plate.
MALDI-TOF analysis and database search
Protein analysis was performed using an Ettan MALDI-
TOF (Amersham Biosciences). Peptides were evaporated
with a N2 laser at 337 nm, and using a delayed extrac-
tion approach. They were accelerated with 20 Kv injec-
tion pulse for time of flight analysis. Each spectrum was
the cumulative average of 300 laser shots. The search
program ProFound, developed by The Rockefeller Uni-
versity http://129.85.19.192/profound_bin/WebPro-
Found.exe was used for protein identification by peptide
mass fingerprinting. Spectra were calibrated with trypsin
auto-digestion ion peak m/z (842.510, 2211.1046) as
internal standards.
Western blotting
Cell lysates were prepared by using lysis buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1%
SDS, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 1× pro-
tease inhibitor cocktail). The extracts were incubated on
ice, spun at 14,000× g for 20 min at 4°C and the super-
natants were collected. Protein concentrations were
determined by Bradford assay (Bio-Rad), and the protein
(50-100 μg) was separated by electrophoresis on 4-12%
NuPAGE Bis-Tris gels (Novex). Proteins were then
transferred to Hybond ECL transfer membranes to eval-
uate their expression using PGM3 (Santa Cruz Bio-
technologies) and b-actin (Sigma) antibodies.
TUNEL assay
Apoptotic cell death was examined by using DeadEnd™-
fluorometric TUNEL assay kit as described in the manu-
facturer’s instructions. Briefly, cells were plated onto the
poly-L-lysine-coated slides, fixed with 4% paraformalde-
hyde for 15 min and incubated in TdT enzyme buffer
containing fluorescein-12-dUTP for 1 h at 37°C. After
mounting in medium containing DAPI (Vectashield,
Vector Labs), cells were visualized under a Carl Zeiss
LSM5 confocal microscope.
siRNA transfection
Cells were transiently transfected with PGM3 or control
siRNA (Santa Cruz Biotechnology, Santa Cruz, CA) at
50 nM of final concentration by using INTERFERin
siRNA transfection reagent (Polyplus transfection) for
72 h.
RT-PCR
Total RNA was prepared using the Trizol reagent (Invi-
torgen) following the manufacturer’si n s t r u c t i o n sa n d
reverse transcribed to cDNA using oligo-dT and ran-
dom primers. The cDNA was amplified by PCR using
the following specific primers:
PGM3: forward 5’-ACACGCCAAGCCCAATGGACT- 3’,
reverse 5’-TTCTCACTGCTGGGCCTGGT-3’;
GAPDH: forward 5’-TCACCATCTTCCAGGAGCGA-3’
reverse 5’-CACAATGCCGAAGTGGTCGT-3’
PCR conditions were as follows: 92°C for 2 min; 94°C
for 30 sec, 59°C for 30 sec, 72°C for 30 sec (30 cycles);
and 72°C for 5 min. The amplified products were sepa-
rated on 2% agarose gels.
Statistical Analysis
All data were expressed as means ± SD. The statistically
significant differences between control and SFN treated
group were calculated by the Student’s t- test.
Additional material
Additional file 1: Figure S1. Chemical structure of sulforaphane
(SFN). Molecular weight = 177.
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